We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Type II Variations in EU Now Subject to Weekly Start Dates
Type II Variations in EU Now Subject to Weekly Start Dates
Drugmakers will be able to make major changes to their products faster under a new European Medicines Agency policy of scheduling new variations reviews weekly rather than monthly.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor